Share

HCA shares down after previewing Q3

HCA Holdings (NYSE:HCA) last issued its quarterly earnings results on Wednesday, August 5th. The firm’s 50-day moving average is $81.56 and its 200 day moving average is $83.65. HCA Holdings has a 1-year low of $43.91 and a 1-year high of $95.49. The stock is ranging from $73.38 to $76.21, and is market capitalization right now is $47.87 billion.

Advertisement

TheStreet Ratings team rates HCA HOLDINGS INC as a Buy with a ratings score of B-.

HCA Holdings Inc (NYSE:HCA) is trading at $70.92, losing -6.71%. (NYSE:HCA) at $102.12. The standard deviation of short term price target has been estimated at $7.3, implying that the actual price may fluctuate by this value. The company’s strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share and increase in net income. Barclays reissued an overweight rating and set a $103.00 price target (up previously from $84.00) on shares of HCA Holdings in a report on Thursday, July 16th. Finally, Zacks downgraded shares of HCA Holdings from a “buy” rating to a “hold” rating in a research report on Monday, August 17th.

The company is expected to announce next quarter earnings on October 27, at consensus estimate of $1.24. They issued a neutral rating and a $98.00 price objective for the company. With a 10-days average volume of 3.51 million shares, the number of days required to cover the short positions stand at 2.5 days. The company reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.03. This contrast with $1.14 billion stated in the same period of the preceding year, a decrease of 12%.

HCA Holdings, Inc., through its auxiliaries, provides health care services in the United States. Four investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock.

The company warned last quarter that benefits from the Affordabe Care Act would taper off over the rest of the year. Same facility uninsured admissions made up 8 percent of total admissions this quarter – up from 7.3 percent a year ago. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The shares were sold at an average price of $91.24, for a total transaction of $1,277,360.00. Following the sale, the insider now owns 4,451 shares of the company’s stock, valued at approximately $371,302.42.

The Nashville, Tennessee, company said Wednesday after markets closed that it will report earnings of about $1.17 per share on around $9.86 billion in revenue for the quarter that ended September 30. The disclosure for this sale can be found here.

Advertisement

HCA Holdings, Inc. (HCA) is a holding company whose affiliates owns and operates hospitals and related healthcare entities. The Company is a health care services company. The Company owns and operates approximately 165 hospitals and approximately 115 freestanding surgery centers in 20 states of the United States and London, the United Kingdom. The Company’s general, acute care hospitals supply a variety of services to accommodate medical specializations, such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, in addition to diagnostic and emergency services. The general, acute care hospitals offer outpatient services, such as cardiology, lab, radiology, respiratory therapy, outpatient surgery and physical therapy.

Hospital operator HCA estimates third-quarter profit below estimates